Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corp (EW)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 47,071,700
  • Shares Outstanding, K 207,969
  • Annual Sales, $ 3,723 M
  • Annual Income, $ 722,200 K
  • 60-Month Beta 0.84
  • Price/Sales 12.77
  • Price/Cash Flow 44.19
  • Price/Book 13.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 1.22
  • Number of Estimates 12
  • High Estimate 1.23
  • Low Estimate 1.19
  • Prior Year 1.07
  • Growth Rate Est. (year over year) +14.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
213.23 +6.73%
on 10/02/19
230.19 -1.13%
on 10/11/19
+8.16 (+3.72%)
since 09/17/19
3-Month
189.77 +19.92%
on 07/18/19
230.19 -1.13%
on 10/11/19
+37.82 (+19.93%)
since 07/17/19
52-Week
136.44 +66.80%
on 10/29/18
230.19 -1.13%
on 10/11/19
+78.95 (+53.12%)
since 10/17/18

Most Recent Stories

More News
What's in Store for Varian Medical (VAR) in Q4 Earnings?

Varian (VAR) is expected to have gained from core Proton Therapy platform in fiscal Q4.

VAR : 114.79 (+1.16%)
EW : 227.25 (+0.40%)
CAH : 51.08 (+4.10%)
ABC : 89.70 (+4.24%)
What's in Store for Edwards Lifesciences' (EW) Q3 Earnings?

The recent full-market launch of the HemoSphere platform with the FloTrac System and Acumen Hypotension Predictive Index should reflect in Edwards Lifesciences' (EW) third-quarter results.

EW : 227.25 (+0.40%)
VRTX : 178.23 (+1.22%)
XRAY : 54.85 (+1.74%)
AKCA : 18.18 (-7.10%)
Top Research Reports for Southern, Applied Materials & Vertex

Top Research Reports for Southern, Applied Materials & Vertex

VRTX : 178.23 (+1.22%)
SO : 60.98 (-0.18%)
NVDA : 193.22 (-0.51%)
EW : 227.25 (+0.40%)
BHP : 47.69 (-1.00%)
AMAT : 51.96 (+0.78%)
Edwards Life Up 27.7% Since SmarTrend Uptrend Call (EW)

SmarTrend identified an Uptrend for Edwards Life (NYSE:EW) on June 6th, 2019 at $178.72. In approximately 4 months, Edwards Life has returned 27.73% as of today's recent price of $228.27.

EW : 227.25 (+0.40%)
What's in Store for Intuitive Surgical (ISRG) in Q3 Earnings?

Better-than-expected performance at Instruments & Accessories segment and da Vinci procedure growth are likely to aided Intuitive Surgical (ISRG) in Q3 earnings.

ISRG : 531.31 (+0.20%)
EW : 227.25 (+0.40%)
CAH : 51.08 (+4.10%)
ABC : 89.70 (+4.24%)
Edwards Lifesciences Hits a 52-Week High on Solid Prospects

Edwards Lifesciences (EW) has been consistently delivering impressive results.

VAR : 114.79 (+1.16%)
EW : 227.25 (+0.40%)
SYK : 215.84 (+0.04%)
MDT : 108.67 (+0.16%)
Watch for Edwards Life to Potentially Pullback After Gaining 1.05% Yesterday

Edwards Life (NYSE:EW) traded in a range yesterday that spanned from a low of $226.10 to a high of $230.19. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $227.29...

EW : 227.25 (+0.40%)
CINDE Announces: Edwards Lifesciences Invests $100 million to Expand its Operations in Costa Rica

Edwards Lifesciences Corporation, a world leader in innovations for structural heart disease and critical care monitoring aimed at patients, expanded its presence in Costa Rica with a $100 million investment...

EW : 227.25 (+0.40%)
Tandem Diabetes is Among the Companies in the Health Care Equipment Industry with the Best Relative Performance (TNDM, EW , DXCM , BAX , HOLX )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

DXCM : 157.66 (+2.46%)
EW : 227.25 (+0.40%)
TNDM : 61.54 (+3.74%)
Edwards Lifesciences To Host Earnings Conference Call On October 23, 2019

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the...

EW : 227.25 (+0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade EW with:

Business Summary

Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards...

See More

Key Turning Points

2nd Resistance Point 229.42
1st Resistance Point 227.88
Last Price 227.25
1st Support Level 225.08
2nd Support Level 223.81

See More

52-Week High 230.19
Last Price 227.25
Fibonacci 61.8% 194.38
Fibonacci 50% 183.32
Fibonacci 38.2% 172.25
52-Week Low 136.44

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar